RNA Cloning Backbones

Optimized RNA Backbones for Enhanced Vaccine and Therapeutic Development

Aldevron's backbone options are designed to enhance mRNA production, making them highly suitable for developing vaccines and therapeutics. Our various constructs feature a T7 promoter for RNA production, and options with encoded poly(a) region and proprietary 5’ UTR sequence.

Key Features of our Proprietary 5’ UTR mRNA Backbones include

Unique UTR Sequences

We offer two options with different UTR sequences which allows researchers to determine which UTR configuration works best for RNA stability and translation efficiency in your specific application.

No License Fee

These backbones are available without licensing fees. This can significantly reduce the financial burden on researchers and companies developing RNA-based products.

Ideal for RNA Development

Optimized for efficient product of high-quality RNA, these backbones are perfect for developing various RNA-based applications, including vaccines and therapies.

Flexible and Ready to Use

The flexible and ready to use backbones allow researchers to quickly integrate these 5’ UTR sequences into your mRNA manufacturing workflows.

Practical Applications

  • RNA Vaccines: The optimized backbones can be used to produce high-quality mRNA for vaccines, ensuring robust immune responses and effective protection against diseases.
  • RNA Therapies: For therapeutic applications, the stability and efficiency provided by these backbones can enhance the delivery and efficacy of RNA-based treatments.

By leveraging Aldevron's proprietary backbones, you can streamline their RNA production processes, reduce costs, and improve the quality and effectiveness of their RNA vaccines and therapies.

Aldevron's cloning vectors are available as free samples. If you are interested, please fill out the Request Sample form.

pALD-UTR Quality Control Specifications
Appearance Clear and Colorless
Buffer TE
Concentration 1.0mg/mL +/- 10%
DNA Homogeneity ≥ 80% Supercoiled
Endotoxin ≤ 100 EU/mg
Identity Size Confirmed Versus Supercoiled Marker
Plasmid Identity Identical to Reference Sequence
ABS 260/280 Ratio Purity 1.80 – 2.00
Residual Host Genomic DNA ≤ 5%
Residual Host RNA Not Visible at 200 ng Load
Restriction Digest Matches Expected Restriction Pattern

REQUEST A COMPLETE COA

Additional Beneficial mRNA Backbones

We also offer royalty free non-proprietary backbones without a license fee for different RNA applications; pALD-CV42 [72] and pALD-CV42 [T7-Poly(A)]. These backbones provide additional flexibility for our clients to clone in their own specific UTR sequence(s).


Learn more about pALD-CV42[T7] and pALD-CV42 [T7-Poly(A)]

pALD-CV42 [T7] and pALD-CV42 [T7-Poly(A)] Quality Control Specifications
Appearance Clear and Colorless
Buffer TE
Concentration 1.0mg/mL +/- 10%
DNA Homogeneity ≥ 80% Supercoiled
Endotoxin ≤ 100 EU/mg
Identity Size Confirmed Versus Supercoiled Marker
Plasmid Identity Identical to Reference Sequence
ABS 260/280 Ratio Purity 1.80 – 2.00
Residual Host Genomic DNA ≤ 5%
Residual Host RNA Not Visible at 200 ng Load
Restriction Digest Matches Expected Restriction Pattern

REQUEST A COMPLETE COA

pALD-CV42 [T7] Map_WPRE pALD-CV42 [T7] Map_WPRE
pALD-CV42 [T7-PolyA] Map_WPRE pALD-CV42 [T7-PolyA] Map_WPRE

Interested in rAAV Manufacturing? Check out rAAV specific ITR cloning vectors.